The global Pet Disease Diagnostic Reagent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Pet disease diagnostic reagents are a type of testing tools designed specifically for pets to quickly identify pathogens or specific disease markers in pets. These reagents usually contain specific antibodies or nucleic acid probes, and use techniques such as immunochromatography, enzyme-linked immunosorbent assay (ELISA) or polymerase chain reaction (PCR) to detect pathogenic components in pet blood, urine or other body fluid samples. They provide pet owners and veterinarians with a fast and accurate means of disease diagnosis, which helps to formulate treatment strategies and preventive measures in a timely manner. The application of pet disease detection and diagnostic reagents has significantly improved the quality and efficiency of pet medical services.

From a downstream perspective, Cat accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Pet Disease Diagnostic Reagent leading manufacturers including Idvet, IDEXX, Diogene, Bio-Rad, Harbin Guosheng Biomedical Laboratory, Hangzhou LifeReal Biotechnology, USTAR BIOTECHNOLOGIES (HANGZHOU), Nanjing Synthgene Medical Technology, etc., dominate supply; the top five capture approximately % of global revenue, with Idvet leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pet Disease Diagnostic Reagent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Pet Disease Diagnostic Reagent Market Report

Report Metric	Details
Report Name	Pet Disease Diagnostic Reagent Market
Segment by Type	Colloidal Gold Detection Reagents Enzyme-linked Immunosorbent Assay Reagents Fluorescent PCR Detection Reagents Nucleic Acid Detection Reagents
Segment by Application	Cat Dog Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Idvet, IDEXX, Diogene, Bio-Rad, Harbin Guosheng Biomedical Laboratory, Hangzhou LifeReal Biotechnology, USTAR BIOTECHNOLOGIES (HANGZHOU), Nanjing Synthgene Medical Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Pet Disease Diagnostic Reagent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pet Disease Diagnostic Reagent Market report?

Ans: The main players in the Pet Disease Diagnostic Reagent Market are Idvet, IDEXX, Diogene, Bio-Rad, Harbin Guosheng Biomedical Laboratory, Hangzhou LifeReal Biotechnology, USTAR BIOTECHNOLOGIES (HANGZHOU), Nanjing Synthgene Medical Technology

What are the Application segmentation covered in the Pet Disease Diagnostic Reagent Market report?

Ans: The Applications covered in the Pet Disease Diagnostic Reagent Market report are Cat, Dog, Others

What are the Type segmentation covered in the Pet Disease Diagnostic Reagent Market report?

Ans: The Types covered in the Pet Disease Diagnostic Reagent Market report are Colloidal Gold Detection Reagents, Enzyme-linked Immunosorbent Assay Reagents, Fluorescent PCR Detection Reagents, Nucleic Acid Detection Reagents

1 Study Coverage

1.1 Introduction to Pet Disease Diagnostic Reagent: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Pet Disease Diagnostic Reagent Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Colloidal Gold Detection Reagents

1.2.3 Enzyme-linked Immunosorbent Assay Reagents

1.2.4 Fluorescent PCR Detection Reagents

1.2.5 Nucleic Acid Detection Reagents

1.3 Market Segmentation by Application

1.3.1 Global Pet Disease Diagnostic Reagent Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Cat

1.3.3 Dog

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pet Disease Diagnostic Reagent Revenue Estimates and Forecasts 2020-2031

2.2 Global Pet Disease Diagnostic Reagent Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Pet Disease Diagnostic Reagent Sales Estimates and Forecasts 2020-2031

2.4 Global Pet Disease Diagnostic Reagent Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Pet Disease Diagnostic Reagent Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Pet Disease Diagnostic Reagent Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Colloidal Gold Detection Reagents Market Size by Manufacturers

3.5.2 Enzyme-linked Immunosorbent Assay Reagents Market Size by Manufacturers

3.5.3 Fluorescent PCR Detection Reagents Market Size by Manufacturers

3.5.4 Nucleic Acid Detection Reagents Market Size by Manufacturers

3.6 Global Pet Disease Diagnostic Reagent Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Pet Disease Diagnostic Reagent Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Pet Disease Diagnostic Reagent Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Pet Disease Diagnostic Reagent Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Pet Disease Diagnostic Reagent Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Pet Disease Diagnostic Reagent Sales and Revenue by Type (2020-2031)

6.4 North America Pet Disease Diagnostic Reagent Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Pet Disease Diagnostic Reagent Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Pet Disease Diagnostic Reagent Sales and Revenue by Type (2020-2031)

7.4 Europe Pet Disease Diagnostic Reagent Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Pet Disease Diagnostic Reagent Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Pet Disease Diagnostic Reagent Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Pet Disease Diagnostic Reagent Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Pet Disease Diagnostic Reagent Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Pet Disease Diagnostic Reagent Sales and Revenue by Type (2020-2031)

9.4 Central and South America Pet Disease Diagnostic Reagent Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Pet Disease Diagnostic Reagent Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Pet Disease Diagnostic Reagent Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Pet Disease Diagnostic Reagent Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Pet Disease Diagnostic Reagent Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Idvet

11.1.1 Idvet Corporation Information

11.1.2 Idvet Business Overview

11.1.3 Idvet Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.1.4 Idvet Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Idvet Pet Disease Diagnostic Reagent Sales by Product in 2024

11.1.6 Idvet Pet Disease Diagnostic Reagent Sales by Application in 2024

11.1.7 Idvet Pet Disease Diagnostic Reagent Sales by Geographic Area in 2024

11.1.8 Idvet Pet Disease Diagnostic Reagent SWOT Analysis

11.1.9 Idvet Recent Developments

11.2 IDEXX

11.2.1 IDEXX Corporation Information

11.2.2 IDEXX Business Overview

11.2.3 IDEXX Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.2.4 IDEXX Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 IDEXX Pet Disease Diagnostic Reagent Sales by Product in 2024

11.2.6 IDEXX Pet Disease Diagnostic Reagent Sales by Application in 2024

11.2.7 IDEXX Pet Disease Diagnostic Reagent Sales by Geographic Area in 2024

11.2.8 IDEXX Pet Disease Diagnostic Reagent SWOT Analysis

11.2.9 IDEXX Recent Developments

11.3 Diogene

11.3.1 Diogene Corporation Information

11.3.2 Diogene Business Overview

11.3.3 Diogene Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.3.4 Diogene Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Diogene Pet Disease Diagnostic Reagent Sales by Product in 2024

11.3.6 Diogene Pet Disease Diagnostic Reagent Sales by Application in 2024

11.3.7 Diogene Pet Disease Diagnostic Reagent Sales by Geographic Area in 2024

11.3.8 Diogene Pet Disease Diagnostic Reagent SWOT Analysis

11.3.9 Diogene Recent Developments

11.4 Bio-Rad

11.4.1 Bio-Rad Corporation Information

11.4.2 Bio-Rad Business Overview

11.4.3 Bio-Rad Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.4.4 Bio-Rad Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Bio-Rad Pet Disease Diagnostic Reagent Sales by Product in 2024

11.4.6 Bio-Rad Pet Disease Diagnostic Reagent Sales by Application in 2024

11.4.7 Bio-Rad Pet Disease Diagnostic Reagent Sales by Geographic Area in 2024

11.4.8 Bio-Rad Pet Disease Diagnostic Reagent SWOT Analysis

11.4.9 Bio-Rad Recent Developments

11.5 Harbin Guosheng Biomedical Laboratory

11.5.1 Harbin Guosheng Biomedical Laboratory Corporation Information

11.5.2 Harbin Guosheng Biomedical Laboratory Business Overview

11.5.3 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.5.4 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales by Product in 2024

11.5.6 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales by Application in 2024

11.5.7 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent Sales by Geographic Area in 2024

11.5.8 Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent SWOT Analysis

11.5.9 Harbin Guosheng Biomedical Laboratory Recent Developments

11.6 Hangzhou LifeReal Biotechnology

11.6.1 Hangzhou LifeReal Biotechnology Corporation Information

11.6.2 Hangzhou LifeReal Biotechnology Business Overview

11.6.3 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.6.4 Hangzhou LifeReal Biotechnology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Hangzhou LifeReal Biotechnology Recent Developments

11.7 USTAR BIOTECHNOLOGIES (HANGZHOU)

11.7.1 USTAR BIOTECHNOLOGIES (HANGZHOU) Corporation Information

11.7.2 USTAR BIOTECHNOLOGIES (HANGZHOU) Business Overview

11.7.3 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.7.4 USTAR BIOTECHNOLOGIES (HANGZHOU) Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments

11.8 Nanjing Synthgene Medical Technology

11.8.1 Nanjing Synthgene Medical Technology Corporation Information

11.8.2 Nanjing Synthgene Medical Technology Business Overview

11.8.3 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Product Models, Descriptions and Specifications

11.8.4 Nanjing Synthgene Medical Technology Pet Disease Diagnostic Reagent Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Nanjing Synthgene Medical Technology Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Pet Disease Diagnostic Reagent Industry Chain

12.2 Pet Disease Diagnostic Reagent Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Pet Disease Diagnostic Reagent Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Pet Disease Diagnostic Reagent Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Pet Disease Diagnostic Reagent Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Pet Disease Diagnostic Reagent Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Harbin Guosheng Biomedical Laboratory

Hangzhou LifeReal Biotechnology

USTAR BIOTECHNOLOGIES (HANGZHOU)

Nanjing Synthgene Medical Technology

List of Tables

Table 1. Global Pet Disease Diagnostic Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Pet Disease Diagnostic Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Pet Disease Diagnostic Reagent Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Pet Disease Diagnostic Reagent Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Pet Disease Diagnostic Reagent Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Pet Disease Diagnostic Reagent Sales by Region (2020-2025) & (K Units)

Table 8. Global Pet Disease Diagnostic Reagent Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Pet Disease Diagnostic Reagent Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Pet Disease Diagnostic Reagent Sales Share by Manufacturers (2020-2025)

Table 12. Global Pet Disease Diagnostic Reagent Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Pet Disease Diagnostic Reagent Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Pet Disease Diagnostic Reagent by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Disease Diagnostic Reagent as of 2024)

Table 16. Global Pet Disease Diagnostic Reagent Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Pet Disease Diagnostic Reagent Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Pet Disease Diagnostic Reagent Manufacturing Base and Headquarters

Table 19. Global Pet Disease Diagnostic Reagent Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Pet Disease Diagnostic Reagent Sales by Type (2020-2025) & (K Units)

Table 23. Global Pet Disease Diagnostic Reagent Sales by Type (2026-2031) & (K Units)

Table 24. Global Pet Disease Diagnostic Reagent Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Pet Disease Diagnostic Reagent Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Pet Disease Diagnostic Reagent ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Pet Disease Diagnostic Reagent Sales by Application (2020-2025) & (K Units)

Table 29. Global Pet Disease Diagnostic Reagent Sales by Application (2026-2031) & (K Units)

Table 30. Pet Disease Diagnostic Reagent High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Pet Disease Diagnostic Reagent Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Pet Disease Diagnostic Reagent Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Pet Disease Diagnostic Reagent ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Pet Disease Diagnostic Reagent Growth Accelerators and Market Barriers

Table 37. North America Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Pet Disease Diagnostic Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Pet Disease Diagnostic Reagent Growth Accelerators and Market Barriers

Table 40. Europe Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Pet Disease Diagnostic Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Pet Disease Diagnostic Reagent Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Pet Disease Diagnostic Reagent Growth Accelerators and Market Barriers

Table 45. Southeast Asia Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Pet Disease Diagnostic Reagent Investment Opportunities and Key Challenges

Table 47. Central and South America Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Pet Disease Diagnostic Reagent Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Pet Disease Diagnostic Reagent Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Idvet Corporation Information

Table 51. Idvet Description and Major Businesses

Table 52. Idvet Product Models, Descriptions and Specifications

Table 53. Idvet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Idvet Sales Value Proportion by Product in 2024

Table 55. Idvet Sales Value Proportion by Application in 2024

Table 56. Idvet Sales Value Proportion by Geographic Area in 2024

Table 57. Idvet Pet Disease Diagnostic Reagent SWOT Analysis

Table 58. Idvet Recent Developments

Table 59. IDEXX Corporation Information

Table 60. IDEXX Description and Major Businesses

Table 61. IDEXX Product Models, Descriptions and Specifications

Table 62. IDEXX Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. IDEXX Sales Value Proportion by Product in 2024

Table 64. IDEXX Sales Value Proportion by Application in 2024

Table 65. IDEXX Sales Value Proportion by Geographic Area in 2024

Table 66. IDEXX Pet Disease Diagnostic Reagent SWOT Analysis

Table 67. IDEXX Recent Developments

Table 68. Diogene Corporation Information

Table 69. Diogene Description and Major Businesses

Table 70. Diogene Product Models, Descriptions and Specifications

Table 71. Diogene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Diogene Sales Value Proportion by Product in 2024

Table 73. Diogene Sales Value Proportion by Application in 2024

Table 74. Diogene Sales Value Proportion by Geographic Area in 2024

Table 75. Diogene Pet Disease Diagnostic Reagent SWOT Analysis

Table 76. Diogene Recent Developments

Table 77. Bio-Rad Corporation Information

Table 78. Bio-Rad Description and Major Businesses

Table 79. Bio-Rad Product Models, Descriptions and Specifications

Table 80. Bio-Rad Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Bio-Rad Sales Value Proportion by Product in 2024

Table 82. Bio-Rad Sales Value Proportion by Application in 2024

Table 83. Bio-Rad Sales Value Proportion by Geographic Area in 2024

Table 84. Bio-Rad Pet Disease Diagnostic Reagent SWOT Analysis

Table 85. Bio-Rad Recent Developments

Table 86. Harbin Guosheng Biomedical Laboratory Corporation Information

Table 87. Harbin Guosheng Biomedical Laboratory Description and Major Businesses

Table 88. Harbin Guosheng Biomedical Laboratory Product Models, Descriptions and Specifications

Table 89. Harbin Guosheng Biomedical Laboratory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Harbin Guosheng Biomedical Laboratory Sales Value Proportion by Product in 2024

Table 91. Harbin Guosheng Biomedical Laboratory Sales Value Proportion by Application in 2024

Table 92. Harbin Guosheng Biomedical Laboratory Sales Value Proportion by Geographic Area in 2024

Table 93. Harbin Guosheng Biomedical Laboratory Pet Disease Diagnostic Reagent SWOT Analysis

Table 94. Harbin Guosheng Biomedical Laboratory Recent Developments

Table 95. Hangzhou LifeReal Biotechnology Corporation Information

Table 96. Hangzhou LifeReal Biotechnology Description and Major Businesses

Table 97. Hangzhou LifeReal Biotechnology Product Models, Descriptions and Specifications

Table 98. Hangzhou LifeReal Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Hangzhou LifeReal Biotechnology Recent Developments

Table 100. USTAR BIOTECHNOLOGIES (HANGZHOU) Corporation Information

Table 101. USTAR BIOTECHNOLOGIES (HANGZHOU) Description and Major Businesses

Table 102. USTAR BIOTECHNOLOGIES (HANGZHOU) Product Models, Descriptions and Specifications

Table 103. USTAR BIOTECHNOLOGIES (HANGZHOU) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. USTAR BIOTECHNOLOGIES (HANGZHOU) Recent Developments

Table 105. Nanjing Synthgene Medical Technology Corporation Information

Table 106. Nanjing Synthgene Medical Technology Description and Major Businesses

Table 107. Nanjing Synthgene Medical Technology Product Models, Descriptions and Specifications

Table 108. Nanjing Synthgene Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Nanjing Synthgene Medical Technology Recent Developments

Table 110. Key Raw Materials Distribution

Table 111. Raw Materials Key Suppliers

Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 113. Milestones in Production Technology Evolution

Table 114. Distributors List

Table 115. Market Trends and Market Evolution

Table 116. Market Drivers and Opportunities

Table 117. Market Challenges, Risks, and Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Pet Disease Diagnostic Reagent Product Picture

Figure 2. Global Pet Disease Diagnostic Reagent Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Colloidal Gold Detection Reagents Product Picture

Figure 4. Enzyme-linked Immunosorbent Assay Reagents Product Picture

Figure 5. Fluorescent PCR Detection Reagents Product Picture

Figure 6. Nucleic Acid Detection Reagents Product Picture

Figure 7. Global Pet Disease Diagnostic Reagent Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Cat

Figure 9. Dog

Figure 10. Others

Figure 11. Pet Disease Diagnostic Reagent Report Years Considered

Figure 12. Global Pet Disease Diagnostic Reagent Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 14. Global Pet Disease Diagnostic Reagent Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Pet Disease Diagnostic Reagent Revenue Market Share by Region (2020-2031)

Figure 16. Global Pet Disease Diagnostic Reagent Sales (2020-2031) & (K Units)

Figure 17. Global Pet Disease Diagnostic Reagent Sales (CAGR) by Region (2020-2031) (K Units)

Figure 18. Global Pet Disease Diagnostic Reagent Sales Market Share by Region (2020-2031)

Figure 19. Top 5 and Top 10 Manufacturers Pet Disease Diagnostic Reagent Sales Volume Market Share in 2024

Figure 20. Global Pet Disease Diagnostic Reagent Revenue Market Share Ranking (2024)

Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 22. Colloidal Gold Detection Reagents Revenue Market Share by Manufacturer in 2024

Figure 23. Enzyme-linked Immunosorbent Assay Reagents Revenue Market Share by Manufacturer in 2024

Figure 24. Fluorescent PCR Detection Reagents Revenue Market Share by Manufacturer in 2024

Figure 25. Nucleic Acid Detection Reagents Revenue Market Share by Manufacturer in 2024

Figure 26. Global Pet Disease Diagnostic Reagent Sales Market Share by Type (2020-2031)

Figure 27. Global Pet Disease Diagnostic Reagent Revenue Market Share by Type (2020-2031)

Figure 28. Global Pet Disease Diagnostic Reagent Sales Market Share by Application (2020-2031)

Figure 29. Global Pet Disease Diagnostic Reagent Revenue Market Share by Application (2020-2031)

Figure 30. North America Pet Disease Diagnostic Reagent Sales YoY (2020-2031) & (K Units)

Figure 31. North America Pet Disease Diagnostic Reagent Revenue YoY (2020-2031) & (US$ Million)

Figure 32. North America Top 5 Manufacturers Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) in 2024

Figure 33. North America Pet Disease Diagnostic Reagent Sales Volume (K Units) by Type (2020- 2031)

Figure 34. North America Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 35. North America Pet Disease Diagnostic Reagent Sales Volume (K Units) by Application (2020-2031)

Figure 36. North America Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Application (2020-2031)

Figure 37. US Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 38. Canada Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 39. Mexico Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 40. Europe Pet Disease Diagnostic Reagent Sales YoY (2020-2031) & (K Units)

Figure 41. Europe Pet Disease Diagnostic Reagent Revenue YoY (2020-2031) & (US$ Million)

Figure 42. Europe Top 5 Manufacturers Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) in 2024

Figure 43. Europe Pet Disease Diagnostic Reagent Sales Volume (K Units) by Type (2020-2031)

Figure 44. Europe Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Type (2020-2031)

Figure 45. Europe Pet Disease Diagnostic Reagent Sales Volume (K Units) by Application (2020-2031)

Figure 46. Europe Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Application (2020-2031)

Figure 47. Germany Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 48. France Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 49. U.K. Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 50. Italy Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 51. Russia Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 52. Asia-Pacific Pet Disease Diagnostic Reagent Sales YoY (2020-2031) & (K Units)

Figure 53. Asia-Pacific Pet Disease Diagnostic Reagent Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Asia-Pacific Top 8 Manufacturers Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) in 2024

Figure 55. Asia-Pacific Pet Disease Diagnostic Reagent Sales Volume (K Units) by Type (2020- 2031)

Figure 56. Asia-Pacific Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 57. Asia-Pacific Pet Disease Diagnostic Reagent Sales Volume (K Units) by Application (2020-2031)

Figure 58. Asia-Pacific Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Application (2020-2031)

Figure 59. Indonesia Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 60. Japan Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 61. South Korea Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 62. China Taiwan Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 63. India Pet Disease Diagnostic Reagent Revenue (2020-2031) & (US$ Million)

Figure 64. Central and South America Pet Disease Diagnostic Reagent Sales YoY (2020-2031) & (K Units)

Figure 65. Central and South America Pet Disease Diagnostic Reagent Revenue YoY (2020-2031) & (US$ Million)

Figure 66. Central and South America Top 5 Manufacturers Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) in 2024

Figure 67. Central and South America Pet Disease Diagnostic Reagent Sales Volume (K Units) by Type (2021-2031)

Figure 68. Central and South America Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Type (2020-2031)

Figure 69. Central and South America Pet Disease Diagnostic Reagent Sales Volume (K Units) by Application (2020-2031)

Figure 70. Central and South America Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Application (2020-2031)

Figure 71. Brazil Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 72. Argentina Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 73. Middle East, and Africa Pet Disease Diagnostic Reagent Sales YoY (2020-2031) & (K Units)

Figure 74. Middle East and Africa Pet Disease Diagnostic Reagent Revenue YoY (2020-2031) & (US$ Million)

Figure 75. Middle East and Africa Top 5 Manufacturers Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) in 2024

Figure 76. Middle East and Africa Pet Disease Diagnostic Reagent Sales Volume (K Units) by Type (2021-2031)

Figure 77. South America Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Type (2020-2031)

Figure 78. Middle East and Africa Pet Disease Diagnostic Reagent Sales Volume (K Units) by Application (2020-2031)

Figure 79. Middle East and Africa Pet Disease Diagnostic Reagent Sales Revenue (US$ Million) by Application (2020-2031)

Figure 80. GCC Countries Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 81. Turkey Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 82. Egypt Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 83. South Africa Pet Disease Diagnostic Reagent Revenue (2020-2025) & (US$ Million)

Figure 84. Pet Disease Diagnostic Reagent Industry Chain Mapping

Figure 85. Regional Pet Disease Diagnostic Reagent Manufacturing Base Distribution (%)

Figure 86. Global Pet Disease Diagnostic Reagent Production Market Share by Region (2020-2031)

Figure 87. Pet Disease Diagnostic Reagent Production Process

Figure 88. Regional Pet Disease Diagnostic Reagent Production Cost Structure

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions